(S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of IGSF3 mRNA CTD PMID:23825647 1,2-dimethylhydrazine decreases expression ISO RGD:1317197 6480464 1, 2-Dimethylhydrazine results in decreased expression of IGSF3 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGSF3 mRNA CTD PMID:19619570 17beta-estradiol increases expression ISO RGD:1317197 6480464 Estradiol results in increased expression of IGSF3 mRNA CTD PMID:19484750 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IGSF3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGSF3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1307796 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGSF3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1307796 6480464 Tetrachlorodibenzodioxin results in increased expression of IGSF3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317197 6480464 Tetrachlorodibenzodioxin affects the expression of IGSF3 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317197 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IGSF3 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317197 6480464 Tetrachlorodibenzodioxin results in increased expression of IGSF3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGSF3 mRNA CTD PMID:19619570 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of IGSF3 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane increases expression ISO RGD:1307796 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IGSF3 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1317197 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of IGSF3 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1317197 6480464 Fenretinide results in increased expression of IGSF3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of IGSF3 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression ISO RGD:1307796 6480464 Propylthiouracil results in increased expression of IGSF3 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:1307796 6480464 acetamide results in increased expression of IGSF3 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of IGSF3 mRNA CTD PMID:32763439 afimoxifene multiple interactions EXP 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of IGSF3 mRNA] CTD PMID:21233418 antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of IGSF3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of IGSF3 mRNA CTD PMID:33212167 benzo[a]pyrene multiple interactions ISO RGD:1317197 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of IGSF3 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1317197 6480464 Benzo(a)pyrene results in increased expression of IGSF3 mRNA CTD PMID:32417428 benzo[b]fluoranthene multiple interactions ISO RGD:1317197 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 beta-hexachlorocyclohexane increases expression ISO RGD:1317197 6480464 beta-hexachlorocyclohexane results in increased expression of IGSF3 mRNA CTD PMID:25270620 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of IGSF3 mRNA CTD PMID:32858204 bisphenol A affects expression ISO RGD:1307796 6480464 bisphenol A affects the expression of IGSF3 mRNA CTD PMID:25181051 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of IGSF3 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1307796 6480464 bisphenol A results in increased expression of IGSF3 mRNA CTD PMID:30816183 more ... bisphenol A decreases methylation ISO RGD:1317197 6480464 bisphenol A results in decreased methylation of IGSF3 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGSF3 mRNA CTD PMID:27685785 butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of IGSF3 mRNA CTD PMID:26079696 C60 fullerene decreases expression ISO RGD:1307796 6480464 fullerene C60 results in decreased expression of IGSF3 mRNA CTD PMID:19167457 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of IGSF3 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:1317197 6480464 Nanotubes, Carbon analog results in decreased expression of IGSF3 mRNA CTD PMID:25554681 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to IGSF3 gene] CTD PMID:28238834 chromium(6+) affects expression ISO RGD:1317197 6480464 chromium hexavalent ion affects the expression of IGSF3 mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:1317197 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 cisplatin increases expression ISO RGD:1307796 6480464 Cisplatin results in increased expression of IGSF3 mRNA CTD PMID:22023808 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of IGSF3 mRNA CTD PMID:23300844 cyclosporin A increases methylation EXP 6480464 Cyclosporine results in increased methylation of IGSF3 promoter CTD PMID:27989131 dexamethasone increases expression ISO RGD:1317197 6480464 Dexamethasone results in increased expression of IGSF3 mRNA CTD PMID:22733784 dioxygen increases expression ISO RGD:1317197 6480464 Oxygen deficiency results in increased expression of IGSF3 mRNA CTD PMID:24205000 dioxygen affects methylation ISO RGD:1317197 6480464 Oxygen deficiency affects the methylation of IGSF3 promoter CTD PMID:24205000 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of IGSF3 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:1307796 6480464 Endosulfan results in decreased expression of IGSF3 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1317197 6480464 Ethanol results in increased expression of IGSF3 mRNA CTD PMID:30319688 fluoranthene multiple interactions ISO RGD:1317197 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IGSF3 mRNA CTD PMID:28329830 furan increases expression ISO RGD:1307796 6480464 furan results in increased expression of IGSF3 mRNA CTD PMID:27387713 gentamycin decreases expression ISO RGD:1307796 6480464 Gentamicins results in decreased expression of IGSF3 mRNA CTD PMID:33387578 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of IGSF3 mRNA CTD PMID:28988120 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IGSF3 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions EXP 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IGSF3 mRNA] CTD PMID:35811015 methotrexate affects expression ISO RGD:1317197 6480464 Methotrexate affects the expression of IGSF3 mRNA CTD PMID:18502557 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of IGSF3 mRNA CTD PMID:14617803 nicotine increases expression EXP 6480464 Nicotine results in increased expression of IGSF3 mRNA CTD PMID:23825647 oxaliplatin multiple interactions ISO RGD:1307796 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGSF3 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:1307796 6480464 oxaliplatin results in increased expression of IGSF3 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1317197 6480464 Acetaminophen affects the expression of IGSF3 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1307796 6480464 Acetaminophen results in decreased expression of IGSF3 mRNA CTD PMID:33387578 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of IGSF3 mRNA CTD PMID:30851411 rotenone increases expression ISO RGD:1317197 6480464 Rotenone results in increased expression of IGSF3 mRNA CTD PMID:32937126 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IGSF3 mRNA] CTD PMID:35811015 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 succimer multiple interactions ISO RGD:1317197 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGSF3 mRNA CTD PMID:21641980 tebuconazole decreases expression EXP 6480464 tebuconazole results in decreased expression of IGSF3 mRNA CTD PMID:30458266 temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of IGSF3 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1317197 6480464 Testosterone deficiency results in increased expression of IGSF3 mRNA CTD PMID:33848595 testosterone multiple interactions ISO RGD:1317197 6480464 1 more ... CTD PMID:33848595 tetrachloromethane affects expression ISO RGD:1317197 6480464 Carbon Tetrachloride affects the expression of IGSF3 mRNA CTD PMID:17484886 tetraphene multiple interactions ISO RGD:1317197 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 titanium dioxide increases expression ISO RGD:1317197 6480464 titanium dioxide results in increased expression of IGSF3 mRNA CTD PMID:23557971 topotecan increases expression ISO RGD:1307796 6480464 Topotecan results in increased expression of IGSF3 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1307796 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGSF3 mRNA CTD PMID:25729387 trichloroethene decreases expression ISO RGD:1307796 6480464 Trichloroethylene results in decreased expression of IGSF3 mRNA CTD PMID:33387578 trovafloxacin increases expression ISO RGD:1317197 6480464 trovafloxacin results in increased expression of IGSF3 mRNA CTD PMID:35537566 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of IGSF3 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGSF3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF3 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1317197 6480464 Valproic Acid results in increased expression of IGSF3 mRNA CTD PMID:21427059 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of IGSF3 mRNA CTD PMID:25979313 vinclozolin decreases expression ISO RGD:1307796 6480464 vinclozolin results in decreased expression of IGSF3 mRNA CTD PMID:23034163 vinclozolin decreases methylation ISO RGD:1307796 6480464 vinclozolin results in decreased methylation of IGSF3 gene CTD PMID:31682807
